(Z)-N'-Hydroxyisobutyrimidamide

Catalog No.: 
ACLTHM870
CAS No.: 
849833-56-3
Molecular Formula: 
C4H10N2O
Molecular Weight: 
102.14
(Z)-N'-Hydroxyisobutyrimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%
5g95%
10g95%
25g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-N'-Hydroxyisobutyrimidamide
IUPAC NameN-hydroxyisobutyrimidamide
MDL No.MFCD00464225
Molecular FormulaC4H10N2O
Molecular Weight102.14
SMILESCC(C)C(NO)=N
InChI KeyJHRDEHLFNLLCQS-UHFFFAOYSA-N
Synonym(1Z)-N'-HYDROXY-2-METHYLPROPANIMIDAMIDE;UKRORGSYN-BB BBV-039207;N-Hydroxyisobutyrimidamide;(1Z)-N'-hydroxy-2-methylpropanimidamide(SALTDATA: FREE);N'-hydroxy-2-methyl-propionamidine;(Z)-N'-Hydroxyisobutyrimidamide;Propanimidamide, N-hydroxy-2-methyl-, (1Z)-
CAS No.849833-56-3

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLTHM870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLTHM870 route product structure diagram
    ACLTHM870849833-56-3In Stock
Inquiry

2. ACLTHM870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLTHM870 route product structure diagram
    ACLTHM870849833-56-3In Stock
Inquiry

3. ACLTHM870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLTHM870 route product structure diagram
    ACLTHM870849833-56-3In Stock
Inquiry

Comments (0)